Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Tritium release from (19-/sup 3/H)-19,19-difluoroandrost-4-ene-3,17-dione during inactivation of aromatase

Conference · · Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States)
OSTI ID:6992162
Aromatase is a cytochrome P-450 enzyme involved in the conversion of 4-androstene-3,17-dione to estrogen via sequential oxidations at the 19-methyl group. Previous studies from this laboratory have shown that 19,19-difluoro-4-androstene-3,17-dione (1) is a mechanism-based inactivator of aromatase, with Ki=1..mu..M. The mechanism of inactivation was postulated to involve enzymic oxidation at, and hydrogen loss from the 19-carbon. To test this proposal, (19-/sup 3/H)-19,19-difluoro-4-androstene-3,17-dione (2) with specific activity of 34 mCi/mmole, was synthesized to study the release of tritium into solution during the enzyme inactivation process. Incubation of (19-/sup 3/H)-19,19-difluoro-4-androstene-3,17-dione (11..mu..M) with human term placental microsomal aromatase at protein concentrations of 327 to 654..mu..g enzyme protein/ml resulted in time-dependent and protein concentration dependent release of tritium. Similar experiments in which enzyme protein, cofactor or both were omitted served as the controls for these studies.
Research Organization:
Johns Hopkins Univ. School of Medicine, Baltimore, MD
OSTI ID:
6992162
Report Number(s):
CONF-8606151-
Conference Information:
Journal Name: Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States) Journal Volume: 45:6
Country of Publication:
United States
Language:
English